W, L., Y, M., X, Z., Y, W., J, W., S, Z., . . . M, Z. (2019). RGDV-modified gemcitabine: A nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine. Dove Medical Press.
Style de citation Chicago (17e éd.)W, Liu, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, et Zhao M. RGDV-modified Gemcitabine: A Nano-medicine Capable of Prolonging Half-life, Overcoming Resistance and Eliminating Bone Marrow Toxicity of Gemcitabine. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)W, Liu, et al. RGDV-modified Gemcitabine: A Nano-medicine Capable of Prolonging Half-life, Overcoming Resistance and Eliminating Bone Marrow Toxicity of Gemcitabine. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.